Perfil
James Ferguson Hill served as Non-Executive Chairman at Genetix Group Ltd. from 2000 to 2010.
He was also Director & Senior VP-Corporate Affairs at SmithKline Beecham Ltd. from 1994 to 2001.
Currently, he is an Independent Director at Akari Therapeutics Plc, a position he has held since 2015 and will hold until 2023.
Antiguos cargos conocidos de James Hill.
| Empresas | Cargo | Fin |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Director/Miembro de la Junta | 30/06/2023 |
Genetix Group Ltd.
Genetix Group Ltd. Medical SpecialtiesHealth Technology Provides solutions for imaging and intelligent image analysis in the life science and diagnostic markets | Presidente | 14/01/2010 |
SmithKline Beecham Ltd.
SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Miembro de la Junta | 01/01/2001 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Genetix Group Ltd.
Genetix Group Ltd. Medical SpecialtiesHealth Technology Provides solutions for imaging and intelligent image analysis in the life science and diagnostic markets | Health Technology |
SmithKline Beecham Ltd.
SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Akari Therapeutics Plc
Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
- Bolsa de valores
- Insiders
- James Hill
















